Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial
Key facts
- Who runs it
- Xijing Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 450 people enrolled
- Started
- 1 Jun 2025
- Ended
- 31 May 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- TIVA ( anesthesia with propofol and remifentanil)
- VA(anesthesia with sevoflurane and remifentanil)
- Record updated
- 15 September 2026
Who can take part
- Age
- 60 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥60 years
- Elective surgery (with an expected duration of 2 hours or more)
- ASA grade Ⅰ-Ⅲ
- Voluntary participation and informed consent obtained
- Diabetes mellitus
Who cannot take part
- Long-term use of sedatives, antipsychotic drugs, or long-term alcohol abuse
- Known neurological or psychiatric diseases (Parkinson's disease, depression, schizophrenia), or cognitive impairment (dementia)
- Patients with a known allergy to the drugs used in this study or those suspected of having propofol infusion syndrome
- Pre-operative BMI≥35 kg/m² (Class II obesity or above)
- Severe hepatic dysfunction (Child-Pugh class C) or pre-operative dialysis-dependent renal dysfunction
- Severe visual or auditory impairments, language barriers, or patients who cannot cooperate
- Neurosurgical patients
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The present study is a multicenter, randomized controlled clinical trial, which plans to enroll 450 diabetic patients aged more than 60 years. The participants will be randomly assigned in a 1:1 ratio and will receive either propofol or sevoflurane for intraoperative anesthesia maintenance to evaluate the impact of these two anesthetic drugs on postoperative delirium. The aim of our study is to explore whether the use of propofol for anesthesia maintenance in elderly diabetic patients undergoing elective non-cardiac major surgery can reduce the incidence of postoperative delirium. This study will provide new perspectives for improving perioperative management in elderly diabetic patients and optimizing anesthesia management strategies to reduce the risk of postoperative delirium.
The 2 groups in the trial
- TIVATreatment being tested
Participants assigned to the TIVA group will receive propofol combined with remifentanil for anesthesia maintenance during the surgery
Treatment: TIVA ( anesthesia with propofol and remifentanil)
- VATreatment being tested
Participants assigned to the VA group will receive sevoflurane combined with remifentanil for anesthesia maintenance during the surgery.
Treatment: VA(anesthesia with sevoflurane and remifentanil)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 15 September 2026